Dannalab — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Dannalab is a specialized contract research organization (CRO) providing essential analytical services for drug development and quality control. Its core offering is cGMP-compliant XRPD and SAXS characterization, critical for assessing polymorphism in small molecules, higher-order protein structure, and nanoparticle drug delivery systems. The company caters to a global pharmaceutical clientele needing EU-compliant testing and supports regulatory submissions from early development through commercial batch release. With accreditation since 2014 and a promise of rapid turnaround, Dannalab positions itself as a nimble, expert partner in a niche but vital segment of the biopharma supply chain.

MicrobiomeDiagnostics

Technology Platform

cGMP-compliant X-ray Powder Diffraction (XRPD) and Small-Angle X-Ray Scattering (SAXS) for solid-state and solution-phase characterization of pharmaceuticals, biopharmaceuticals, and nanoparticles.

Opportunities

Strong growth in biologics, biosimilars, and complex drug delivery systems (e.g., LNPs) is driving increased demand for sophisticated analytical characterization services like SAXS.

Regulatory requirements for EU import testing provide a stable, captive market for its GMP lab services.

The company is well-positioned to be a preferred partner for emerging biotechs developing advanced modalities that require nanoscale structural analysis.

Risk Factors

The business is reliant on the continued regulatory and industry reliance on XRPD/SAXS, with potential disruption from new analytical technologies.

Maintaining cGMP accreditation is critical; any lapse would severely impact operations.

Revenue is subject to cyclicality in pharma R&D spending and competition from both specialized labs and large CROs.

Competitive Landscape

Dannalab competes in a niche segment against other specialized analytical CROs offering X-ray services, as well as the broader analytical divisions of large, full-service contract research organizations (CROs). Its key differentiators are its deep technical expertise in both XRPD and SAXS, its cGMP compliance with a focus on regulatory deliverables, and its positioning as an EU-based lab for mandatory import testing. Competition also comes from pharmaceutical companies' internal analytical departments.

More companies in Diagnostics & Precision Medicine →More companies in Netherlands →